Lactate signalling leads to aggregation of immune-inflammatory hotspots and SLC5A12 blockade promotes their resolution.

Saved in:
Bibliographic Details
Title: Lactate signalling leads to aggregation of immune-inflammatory hotspots and SLC5A12 blockade promotes their resolution.
Authors: Certo M; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK. m.certo@bham.ac.uk., Pontarini E; Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK., Gilbert SG; School of Mathematics, University of Birmingham, Birmingham, UK.; Birmingham Tissue Analytics, Institute of Translational Medicine, University of Birmingham, Birmingham, UK., Schmidt R; Sciomics GmbH, Neckargemünd, Germany., Turner JD; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK., Lucchesi D; Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK., Apostolo D; Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK.; Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy., Cavallaro G; Department of Physics and Astronomy, University of Catania, Catania, Italy., Smith CG; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK., Colafrancesco S; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, and Rheumatology and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS Humanitas Research Hospital, Rozzano, Italy., Campos J; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Propath UK Limited, Hereford, UK., Nayar S; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK., Schröder C; Sciomics GmbH, Neckargemünd, Germany., Fisher BA; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK.; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK., Spill F; School of Mathematics, University of Birmingham, Birmingham, UK., Bombardieri M; Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK. m.bombardieri@qmul.ac.uk., Mauro C; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK. c.mauro@bham.ac.uk.
Source: Nature metabolism [Nat Metab] 2025 Aug; Vol. 7 (8), pp. 1663-1680. Date of Electronic Publication: 2025 Aug 04.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2522-5812 (Electronic) Linking ISSN: 25225812 NLM ISO Abbreviation: Nat Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2522-5812
DOI:10.1038/s42255-025-01331-9